Works matching AU Sonis, Stephen T.

Results: 72
    1
    2
    3
    4
    5
    6
    7
    8

    A Phase III, Randomized, Double-blind, Placebo-controlled, Multinational Trial of Iseganan for the Prevention of Oral Mucositis in Patients Receiving Stomatotoxic Chemotherapy (PROMPT-CT Trial).

    Published in:
    Leukemia & Lymphoma, 2003, v. 44, n. 7, p. 1165, doi. 10.1080/1042819031000079159
    By:
    • Giles, Francis J.;
    • Miller, Carole B.;
    • Hurd, David D.;
    • Wingard, John R.;
    • Fleming, Thomas R.;
    • Sonis, Stephen T.;
    • Bradford, Williamson Z.;
    • Pulliam, Janis G.;
    • Anaissie, Elias J.;
    • Beveridge, Roy A.;
    • Brunvand, Mark M.;
    • Martin, Paul J.;
    • Investigators†, PROMPT-CT Trial
    Publication type:
    Article
    9
    10

    Multi-institutional, randomized, double-blind, placebo-controlled trial to assess the efficacy of a mucoadhesive hydrogel (MuGard) in mitigating oral mucositis symptoms in patients being treated with chemoradiation therapy for cancers of the head and neck

    Published in:
    Cancer (0008543X), 2014, v. 120, n. 9, p. 1433, doi. 10.1002/cncr.28553
    By:
    • Allison, Ron R.;
    • Ambrad, Aaron A.;
    • Arshoun, Youssef;
    • Carmel, Richard J.;
    • Ciuba, Doug F.;
    • Feldman, Elizabeth;
    • Finkelstein, Steven E.;
    • Gandhavadi, Ranjini;
    • Heron, Dwight E.;
    • Lane, Steven C.;
    • Longo, John M.;
    • Meakin, Charles;
    • Papadopoulos, Dimitrios;
    • Pruitt, David E.;
    • Steinbrenner, Lynn M.;
    • Taylor, Michael A.;
    • Wisbeck, William M.;
    • Yuh, Grace E.;
    • Nowotnik, David P.;
    • Sonis, Stephen T.
    Publication type:
    Article
    11
    12

    Multi-institutional, randomized, double-blind, placebo-controlled trial to assess the efficacy of a mucoadhesive hydrogel (MuGard) in mitigating oral mucositis symptoms in patients being treated with chemoradiation therapy for cancers of the head and neck.

    Published in:
    2014
    By:
    • Allison, Ron R;
    • Ambrad, Aaron A;
    • Arshoun, Youssef;
    • Carmel, Richard J;
    • Ciuba, Doug F;
    • Feldman, Elizabeth;
    • Finkelstein, Steven E;
    • Gandhavadi, Ranjini;
    • Heron, Dwight E;
    • Lane, Steven C;
    • Longo, John M;
    • Meakin, Charles;
    • Papadopoulos, Dimitrios;
    • Pruitt, David E;
    • Steinbrenner, Lynn M;
    • Taylor, Michael A;
    • Wisbeck, William M;
    • Yuh, Grace E;
    • Nowotnik, David P;
    • Sonis, Stephen T
    Publication type:
    journal article
    13

    Phase 1b, multicenter, single blinded, placebo-controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subjects with locally advanced head and neck cancer receiving induction chemotherapy.

    Published in:
    Cancer (0008543X), 2013, v. 119, n. 24, p. 4268, doi. 10.1002/cncr.28365
    By:
    • Limaye, Sewanti Atul;
    • Haddad, Robert I.;
    • Cilli, Fiona;
    • Sonis, Stephen T.;
    • Colevas, A. Dimitrios;
    • Brennan, Michael T.;
    • Hu, Kenneth S.;
    • Murphy, Barbara A.
    Publication type:
    Article
    14

    Patient-reported Measurements of Oral Mucositis in Head and Neck Cancer Patients Treated With Radiotherapy With or Without Chemotherapy: Demonstration of Increased Frequency, Severity, Resistance to Palliation, and Impact on Quality of Life.

    Published in:
    Cancer (0008543X), 2008, v. 113, n. 10, p. 2704, doi. 10.1002/cncr.23898
    By:
    • Elting, Linda S.;
    • Keefe, Dorothy M.;
    • Sonis, Stephen T.;
    • Garden, Adam S.;
    • Spijkervet, F. K. L.;
    • Barasch, Andrel;
    • Tishler, Roy B.;
    • Canty, Thomas P.;
    • Kudrimoti, Mahesh K.;
    • Vera-Lionch, Montserrat
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25

    Updated clinical practice guidelines for the prevention and treatment of mucositisThe opinions or views expressed in this professional review are those of the authors and do not necessarily reflect the opinions or recommendations of the publisher or the companies that provided grants toward this process. This article is being published with the full knowledge and consent of the authors. This article may discuss pharmaceutical products and/or uses of products that have not been approved by the U.S. Food and Drug Administration or other regulatory authorities outside of the United States. For approved product information, consult the manufacturer's prescribing information or the applicable regulatory authority. Dosages, indications, and methods of use for compounds that are referred to in this article may be derived from the professional literature or other sources. In vitro and animal data may not correlate with clinical results and do not demonstrate clinical safety or efficacy in hum

    Published in:
    Cancer (0008543X), 2007, v. 109, n. 5, p. 820
    By:
    • Dorothy M. Keefe;
    • Mark M. Schubert;
    • Linda S. Elting;
    • Stephen T. Sonis;
    • Joel B. Epstein;
    • Judith E. Raber‐Durlacher;
    • Cesar A. Migliorati;
    • Deborah B. McGuire;
    • Ronald D. Hutchins;
    • Douglas E. Peterson
    Publication type:
    Article
    26

    Perspectives on cancer therapy-induced mucosal injury.

    Published in:
    Cancer (0008543X), 2004, v. 100, p. 1995
    By:
    • Stephen T. Sonis;
    • Linda S. Elting;
    • Dorothy Keefe;
    • Douglas E. Peterson;
    • Mark Schubert;
    • Martin Hauer-Jensen;
    • B. Nebiyou Bekele;
    • Judith Raber-Durlacher;
    • J. Peter Donnelly;
    • Edward B. Rubenstein
    Publication type:
    Article
    27

    Clinical practice guidelines for the prevention and treatment of cancer therapy–induced oral and gastrointestinal mucositis Panelists included the following individuals: Andrei Barasch, D.M.D., M.D.Sc., University of Detroit Mercy School of Dentistry (Detroit, MI); B. Nebiyou Bekele, Ph.D., The University of Texas M. D. Anderson Cancer Center (Houston, TX); Rene-Jean Bensadoun, M.D., Center Antoine-Lacassagne (Nice, France); Michael Brennan, D.D.S., M.H.S., Carolinas Medical Center (Charlotte, NC); Mark Chambers, D.D.S., The University of Texas M. D. Anderson Cancer Center (Houston, TX); Catherine Cooksley, Ph.D., The University of Texas M. D. Anderson Cancer Center (Houston, TX); Marcio Da Fonseca, D.D.S., M.S., University of Michigan School of Dentistry (Ann Arbor, MI); Kathryn L. Damato, R.D.H., M.S., C.C.R.P., University of Connecticut Health Center (Farmington, CT); Betty Daniel, B.S.N., M.S., The University of Texas M. D. Anderson Cancer

    Published in:
    Cancer (0008543X), 2004, v. 100, p. 2026
    By:
    • Edward B. Rubenstein;
    • Douglas E. Peterson;
    • Mark Schubert;
    • Dorothy Keefe;
    • Deborah McGuire;
    • Joel Epstein;
    • Linda S. Elting;
    • Philip C. Fox;
    • Catherine Cooksley;
    • Stephen T. Sonis
    Publication type:
    Article
    28
    29
    30
    31

    Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Mucositis Study Group.

    Published in:
    1999
    By:
    • Sonis, Stephen T.;
    • Eilers, June P.;
    • Epstein, Joel B.;
    • LeVeque, Francis G.;
    • Liggett, William H.;
    • Mulagha, Mary T.;
    • Peterson, Douglas E.;
    • Rose, Ann H.;
    • Schubert, Mark M.;
    • Spijkervet, Frederik K.;
    • Wittes, Janet P.;
    • Sonis, S T;
    • Eilers, J P;
    • Epstein, J B;
    • LeVeque, F G;
    • Liggett, W H Jr;
    • Mulagha, M T;
    • Peterson, D E;
    • Rose, A H;
    • Schubert, M M
    Publication type:
    journal article
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46

    The Use of Hyperbaric Oxygen for the Prevention and Management of Osteoradionecrosis of the Jaw: A Dana-Farber/ Brigham and Women’s Cancer Center Multidisciplinary Guideline.

    Published in:
    Oncologist, 2017, v. 22, n. 11, p. 1413, doi. 10.1634/theoncologist.2016-0298erratum
    By:
    • Sultan, Ahmed;
    • Hanna, Glenn J.;
    • Margalit, Danielle N.;
    • Chau, Nicole;
    • Goguen, Laura A.;
    • Marty, Francisco M.;
    • Rabinowits, Guilherme;
    • Schoenfeld, Jonathan D.;
    • Sonis, Stephen T.;
    • Thomas, Tom;
    • Tishler, Roy B.;
    • Treister, Nathaniel S.;
    • Villa, Alessandro;
    • Woo, Sook‐Bin;
    • Haddad, Robert;
    • Mawardi, Hani
    Publication type:
    Article
    47

    The Use of Hyperbaric Oxygen for the Prevention and Management of Osteoradionecrosis of the Jaw: A Dana-Farber/Brigham and Women's Cancer Center Multidisciplinary Guideline.

    Published in:
    Oncologist, 2017, v. 22, n. 3, p. 343, doi. 10.1634/theoncologist.2016-0298
    By:
    • Sultan, Ahmed;
    • Hanna, Glenn J.;
    • Margalit, Danielle N.;
    • Chau, Nicole;
    • Goguen, Laura A.;
    • Marty, Francisco M.;
    • Rabinowits, Guilherme;
    • Schoenfeld, Jonathan D.;
    • Sonis, Stephen T.;
    • Thomas, Tom;
    • Tishler, Roy B.;
    • Treister, Nathaniel S.;
    • Villa, Alessandro;
    • Woo, Sook‐Bin;
    • Haddad, Robert;
    • Mawardi, Hani
    Publication type:
    Article
    48
    49
    50